COVID-19 Impact on Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: C79B8BB5D699EN
QYResearch

Abstracts

This report focuses on the global Gastric Cancer Testing, Treatment and Prevention status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastric Cancer Testing, Treatment and Prevention development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Biogen Idec
• Bristol Myers Squibb
• Eli Lilly And Company
• Glaxosmithkline Genentech, Inc
• Hoffmann-La Roche Inc.
• Immunogen Merck & Company
• Novartis
• Pacific Edge Diagnostics Nz
• Pfizer
• Roche/Genentech Oncolytics
• Zova Biotherapeutics Inc.

Market segment by Type, the product can be split into

• Test
• Treatment
• Prevention

Market segment by Application, split into

• Hospitals
• Clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Gastric Cancer Testing, Treatment and Prevention status, future forecast, growth opportunity, key market and key players.
• To present the Gastric Cancer Testing, Treatment and Prevention development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Gastric Cancer Testing, Treatment and Prevention are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastric Cancer Testing, Treatment and Prevention Revenue
1.4 Market Analysis by Type
  1.4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Test
  1.4.3 Treatment
  1.4.4 Prevention
1.5 Market by Application
  1.5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gastric Cancer Testing, Treatment and Prevention Industry Impact
  1.6.1 How the Covid-19 is Affecting the Gastric Cancer Testing, Treatment and Prevention Industry
    1.6.1.1 Gastric Cancer Testing, Treatment and Prevention Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Gastric Cancer Testing, Treatment and Prevention Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Gastric Cancer Testing, Treatment and Prevention Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Gastric Cancer Testing, Treatment and Prevention Market Perspective (2015-2026)
2.2 Gastric Cancer Testing, Treatment and Prevention Growth Trends by Regions
  2.2.1 Gastric Cancer Testing, Treatment and Prevention Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Gastric Cancer Testing, Treatment and Prevention Historic Market Share by Regions (2015-2020)
  2.2.3 Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Gastric Cancer Testing, Treatment and Prevention Market Growth Strategy
  2.3.6 Primary Interviews with Key Gastric Cancer Testing, Treatment and Prevention Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Gastric Cancer Testing, Treatment and Prevention Players by Market Size
  3.1.1 Global Top Gastric Cancer Testing, Treatment and Prevention Players by Revenue (2015-2020)
  3.1.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Players (2015-2020)
  3.1.3 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio
  3.2.1 Global Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Gastric Cancer Testing, Treatment and Prevention Revenue in 2019
3.3 Gastric Cancer Testing, Treatment and Prevention Key Players Head office and Area Served
3.4 Key Players Gastric Cancer Testing, Treatment and Prevention Product Solution and Service
3.5 Date of Enter into Gastric Cancer Testing, Treatment and Prevention Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Gastric Cancer Testing, Treatment and Prevention Historic Market Size by Type (2015-2020)
4.2 Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Type (2021-2026)

5 GASTRIC CANCER TESTING, TREATMENT AND PREVENTION BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)
5.2 Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
6.2 Gastric Cancer Testing, Treatment and Prevention Key Players in North America (2019-2020)
6.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
6.4 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
7.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Europe (2019-2020)
7.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
7.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

8 CHINA

8.1 China Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
8.2 Gastric Cancer Testing, Treatment and Prevention Key Players in China (2019-2020)
8.3 China Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
8.4 China Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
9.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Japan (2019-2020)
9.3 Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
9.4 Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
10.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
10.4 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

11 INDIA

11.1 India Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
11.2 Gastric Cancer Testing, Treatment and Prevention Key Players in India (2019-2020)
11.3 India Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
11.4 India Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size (2015-2020)
12.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020)
12.4 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Biogen Idec
  13.1.1 Biogen Idec Company Details
  13.1.2 Biogen Idec Business Overview and Its Total Revenue
  13.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Introduction
  13.1.4 Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020))
  13.1.5 Biogen Idec Recent Development
13.2 Bristol Myers Squibb
  13.2.1 Bristol Myers Squibb Company Details
  13.2.2 Bristol Myers Squibb Business Overview and Its Total Revenue
  13.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Introduction
  13.2.4 Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.2.5 Bristol Myers Squibb Recent Development
13.3 Eli Lilly And Company
  13.3.1 Eli Lilly And Company Company Details
  13.3.2 Eli Lilly And Company Business Overview and Its Total Revenue
  13.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Introduction
  13.3.4 Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.3.5 Eli Lilly And Company Recent Development
13.4 Glaxosmithkline Genentech, Inc
  13.4.1 Glaxosmithkline Genentech, Inc Company Details
  13.4.2 Glaxosmithkline Genentech, Inc Business Overview and Its Total Revenue
  13.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Introduction
  13.4.4 Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.4.5 Glaxosmithkline Genentech, Inc Recent Development
13.5 Hoffmann-La Roche Inc.
  13.5.1 Hoffmann-La Roche Inc. Company Details
  13.5.2 Hoffmann-La Roche Inc. Business Overview and Its Total Revenue
  13.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Introduction
  13.5.4 Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.5.5 Hoffmann-La Roche Inc. Recent Development
13.6 Immunogen Merck & Company
  13.6.1 Immunogen Merck & Company Company Details
  13.6.2 Immunogen Merck & Company Business Overview and Its Total Revenue
  13.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Introduction
  13.6.4 Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.6.5 Immunogen Merck & Company Recent Development
13.7 Novartis
  13.7.1 Novartis Company Details
  13.7.2 Novartis Business Overview and Its Total Revenue
  13.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Introduction
  13.7.4 Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.7.5 Novartis Recent Development
13.8 Pacific Edge Diagnostics Nz
  13.8.1 Pacific Edge Diagnostics Nz Company Details
  13.8.2 Pacific Edge Diagnostics Nz Business Overview and Its Total Revenue
  13.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Introduction
  13.8.4 Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.8.5 Pacific Edge Diagnostics Nz Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Introduction
  13.9.4 Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 Roche/Genentech Oncolytics
  13.10.1 Roche/Genentech Oncolytics Company Details
  13.10.2 Roche/Genentech Oncolytics Business Overview and Its Total Revenue
  13.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Introduction
  13.10.4 Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  13.10.5 Roche/Genentech Oncolytics Recent Development
13.11 Zova Biotherapeutics Inc.
  10.11.1 Zova Biotherapeutics Inc. Company Details
  10.11.2 Zova Biotherapeutics Inc. Business Overview and Its Total Revenue
  10.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Introduction
  10.11.4 Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
  10.11.5 Zova Biotherapeutics Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Gastric Cancer Testing, Treatment and Prevention Key Market Segments
Table 2. Key Players Covered: Ranking by Gastric Cancer Testing, Treatment and Prevention Revenue
Table 3. Ranking of Global Top Gastric Cancer Testing, Treatment and Prevention Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Test
Table 6. Key Players of Treatment
Table 7. Key Players of Prevention
Table 8. COVID-19 Impact Global Market: (Four Gastric Cancer Testing, Treatment and Prevention Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Gastric Cancer Testing, Treatment and Prevention Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Gastric Cancer Testing, Treatment and Prevention Players to Combat Covid-19 Impact
Table 13. Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2015-2020)
Table 17. Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Gastric Cancer Testing, Treatment and Prevention Market Growth Strategy
Table 23. Main Points Interviewed from Key Gastric Cancer Testing, Treatment and Prevention Players
Table 24. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Players (2015-2020) (Million US$)
Table 25. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Players (2015-2020)
Table 26. Global Top Gastric Cancer Testing, Treatment and Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Cancer Testing, Treatment and Prevention as of 2019)
Table 27. Global Gastric Cancer Testing, Treatment and Prevention by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Gastric Cancer Testing, Treatment and Prevention Product Solution and Service
Table 30. Date of Enter into Gastric Cancer Testing, Treatment and Prevention Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 33. Global Gastric Cancer Testing, Treatment and Prevention Market Size Share by Type (2015-2020)
Table 34. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type (2021-2026)
Table 35. Global Gastric Cancer Testing, Treatment and Prevention Market Size Share by Application (2015-2020)
Table 36. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 37. Global Gastric Cancer Testing, Treatment and Prevention Market Size Share by Application (2021-2026)
Table 38. North America Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 40. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 41. North America Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 42. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 43. North America Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 44. Europe Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 46. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 48. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 50. China Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 51. China Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 52. China Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 53. China Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 54. China Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 55. China Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 56. Japan Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 58. Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 60. Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 64. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 66. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 68. India Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 69. India Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 70. India Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 71. India Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 72. India Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 73. India Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Gastric Cancer Testing, Treatment and Prevention Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Gastric Cancer Testing, Treatment and Prevention Market Share (2019-2020)
Table 76. Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2015-2020)
Table 78. Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2015-2020)
Table 80. Biogen Idec Company Details
Table 81. Biogen Idec Business Overview
Table 82. Biogen Idec Product
Table 83. Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 84. Biogen Idec Recent Development
Table 85. Bristol Myers Squibb Company Details
Table 86. Bristol Myers Squibb Business Overview
Table 87. Bristol Myers Squibb Product
Table 88. Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 89. Bristol Myers Squibb Recent Development
Table 90. Eli Lilly And Company Company Details
Table 91. Eli Lilly And Company Business Overview
Table 92. Eli Lilly And Company Product
Table 93. Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 94. Eli Lilly And Company Recent Development
Table 95. Glaxosmithkline Genentech, Inc Company Details
Table 96. Glaxosmithkline Genentech, Inc Business Overview
Table 97. Glaxosmithkline Genentech, Inc Product
Table 98. Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 99. Glaxosmithkline Genentech, Inc Recent Development
Table 100. Hoffmann-La Roche Inc. Company Details
Table 101. Hoffmann-La Roche Inc. Business Overview
Table 102. Hoffmann-La Roche Inc. Product
Table 103. Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 104. Hoffmann-La Roche Inc. Recent Development
Table 105. Immunogen Merck & Company Company Details
Table 106. Immunogen Merck & Company Business Overview
Table 107. Immunogen Merck & Company Product
Table 108. Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 109. Immunogen Merck & Company Recent Development
Table 110. Novartis Company Details
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 114. Novartis Recent Development
Table 115. Pacific Edge Diagnostics Nz Business Overview
Table 116. Pacific Edge Diagnostics Nz Product
Table 117. Pacific Edge Diagnostics Nz Company Details
Table 118. Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 119. Pacific Edge Diagnostics Nz Recent Development
Table 120. Pfizer Company Details
Table 121. Pfizer Business Overview
Table 122. Pfizer Product
Table 123. Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 124. Pfizer Recent Development
Table 125. Roche/Genentech Oncolytics Company Details
Table 126. Roche/Genentech Oncolytics Business Overview
Table 127. Roche/Genentech Oncolytics Product
Table 128. Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 129. Roche/Genentech Oncolytics Recent Development
Table 130. Zova Biotherapeutics Inc. Company Details
Table 131. Zova Biotherapeutics Inc. Business Overview
Table 132. Zova Biotherapeutics Inc. Product
Table 133. Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020) (Million US$)
Table 134. Zova Biotherapeutics Inc. Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Type: 2020 VS 2026
Figure 2. Test Features
Figure 3. Treatment Features
Figure 4. Prevention Features
Figure 5. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Gastric Cancer Testing, Treatment and Prevention Report Years Considered
Figure 10. Global Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions: 2020 VS 2026
Figure 12. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Players in 2019
Figure 15. Global Top Gastric Cancer Testing, Treatment and Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Cancer Testing, Treatment and Prevention as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gastric Cancer Testing, Treatment and Prevention Revenue in 2019
Figure 17. North America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Biogen Idec Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 26. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol Myers Squibb Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 28. Eli Lilly And Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Eli Lilly And Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 30. Glaxosmithkline Genentech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Glaxosmithkline Genentech, Inc Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 32. Hoffmann-La Roche Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Hoffmann-La Roche Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 34. Immunogen Merck & Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Immunogen Merck & Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 38. Pacific Edge Diagnostics Nz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pacific Edge Diagnostics Nz Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 40. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 42. Roche/Genentech Oncolytics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Roche/Genentech Oncolytics Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 44. Zova Biotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Zova Biotherapeutics Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed